(Q35198613)

7 August 2017

1 reference

title

Experimental approaches to treatment of soft tissue sarcoma (English)

1 reference

7 August 2017

Rosa F Hwang

1

1 reference

PubMed ID

12916466

7 August 2017

Kelly K Hunt

series ordinal

2

1 reference

7 August 2017

1 April 2003

1 reference

Surgical oncology clinics of North America

7 August 2017

1 reference

7 August 2017

12

1 reference

7 August 2017

2

1 reference

7 August 2017

499-521

1 reference

The role of multimodality therapy in soft-tissue sarcoma

7 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900006-1

7 January 2021

Tumor angiogenesis: therapeutic implications

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900006-1

7 January 2021

Angiogenesis in cancer and other diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900006-1

7 January 2021

Angiogenesis: regulators and clinical applications

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900006-1

7 January 2021

Angiogenic heterogeneity: regulation of neoplastic angiogenesis by the organ microenvironment

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900006-1

7 January 2021

Angiogenesis and antiangiogenic approaches to sarcomas

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900006-1

7 January 2021

Vascular-specific growth factors and blood vessel formation

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900006-1

7 January 2021

Patterns of expression and secretion of vascular endothelial growth factor in malignant soft-tissue tumours

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900006-1

7 January 2021

Serum levels of vascular endothelial growth factor and basic fibroblast growth factor in patients with soft-tissue sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900006-1

7 January 2021

Vascular endothelial growth factor and soft tissue sarcomas: tumor expression correlates with grade

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900006-1

7 January 2021

Neuropilin is a mediator of angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900006-1

7 January 2021

Urokinase-plasminogen-activator levels and prognosis in 69 soft-tissue sarcomas

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900006-1

7 January 2021

Angiogenesis in malignant fibrous histiocytoma

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900006-1

7 January 2021

Neovascularity and clinical outcome in high-grade extremity soft tissue sarcomas.

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900006-1

7 January 2021

Relationship of hypoxia to metastatic ability in rodent tumours

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900006-1

7 January 2021

Potent anti-angiogenic action of AGM-1470: comparison to the fumagillin parent

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900006-1

7 January 2021

Suppression of angiogenesis, tumor growth, and wound healing by resveratrol, a natural compound in red wine and grapes

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900006-1

7 January 2021

Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900006-1

7 January 2021

Induction of solid tumor differentiation by the peroxisome proliferator-activated receptor-gamma ligand troglitazone in patients with liposarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900006-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900006-1

1 reference

7 January 2021

Apoptosis: a link between cancer genetics and chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900006-1

7 January 2021

Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900006-1

7 January 2021

Overexpression of bcl-2 protein in synovial sarcoma: a comparative study of other soft tissue spindle cell sarcomas and an additional analysis by fluorescence in situ hybridization

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900006-1

7 January 2021

bcl-2 expression in synovial sarcoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900006-1

7 January 2021

Expression of bcl-2 oncoprotein in benign and malignant spindle cell tumors of soft tissue, skin, serosal surfaces, and gastrointestinal tract.

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900006-1

7 January 2021

Prognostic significance of apoptosis in synovial sarcoma: correlation with clinicopathologic parameters, cell proliferative activity, and expression of apoptosis-related proteins

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900006-1

7 January 2021

The I kappa B proteins: multifunctional regulators of Rel/NF-kappa B transcription factors

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900006-1

7 January 2021

TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900006-1

7 January 2021

Inhibition of the transcription factor nuclear factor-kappa B by adenoviral-mediated expression of I kappa B alpha M results in tumor cell death

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900006-1

7 January 2021

Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900006-1

7 January 2021

p53 and E2F-1 cooperate to mediate apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900006-1

7 January 2021

Role for the double-stranded RNA activated protein kinase PKR in E2F-1-induced apoptosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900006-1

7 January 2021

Chromosomal translocations in sarcomas: prospects for therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900006-1

7 January 2021

A reverse transcriptase-polymerase chain reaction assay in the diagnosis of soft tissue sarcomas

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900006-1

7 January 2021

The hybrid PAX3-FKHR fusion protein of alveolar rhabdomyosarcoma transforms fibroblasts in culture

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900006-1

7 January 2021

Liposarcoma initiated by FUS/TLS-CHOP: the FUS/TLS domain plays a critical role in the pathogenesis of liposarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900006-1

7 January 2021

Expression of the FUS domain restores liposarcoma development in CHOP transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900006-1

7 January 2021

Inhibition of apoptosis by normal and aberrant Fli-1 and erg proteins involved in human solid tumors and leukemias

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900006-1

7 January 2021

EWS-Fli1 antisense oligodeoxynucleotide inhibits proliferation of human Ewing's sarcoma and primitive neuroectodermal tumor cells

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900006-1

7 January 2021

Regulating the neoplastic phenotype using engineered transcriptional repressors

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900006-1

7 January 2021

Targeting tumor specific translocations in sarcomas in pediatric patients for immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900006-1

7 January 2021

Regulated expression of the diphtheria toxin A chain by a tumor-specific chimeric transcription factor results in selective toxicity for alveolar rhabdomyosarcoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900006-1

7 January 2021

Elimination of extrachromosomally amplified MYC genes from human tumor cells reduces their tumorigenicity

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900006-1

7 January 2021

Clinicopathologic correlations and short-term prognosis in musculoskeletal sarcoma with c-myc oncogene amplification

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900006-1

7 January 2021

Prognostic significance of nuclear accumulation of c-myc and mdm2 proteins in synovial sarcoma of the extremities

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900006-1

7 January 2021

mdm-2 inhibits the G1 arrest and apoptosis functions of the p53 tumor suppressor protein

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900006-1

7 January 2021

Soft tissue sarcomas and p53 mutations

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900006-1

7 January 2021

High prognostic significance of Mdm2/p53 co-overexpression in soft tissue sarcomas of the extremities

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900006-1

7 January 2021

Colony formation of soft tissue sarcoma cells is inhibited by lipid-mediated antisense oligodeoxynucleotides targeting the human mdm2 oncogene

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900006-1

7 January 2021

Structure and function of the p53 tumor suppressor gene: clues for rational cancer therapeutic strategies

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900006-1

7 January 2021

Prognostic implications of p53 nuclear overexpression and high proliferation index of Ki-67 in adult soft-tissue sarcomas

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900006-1

7 January 2021

Wild type p53 sensitizes soft tissue sarcoma cells to doxorubicin by down-regulating multidrug resistance-1 expression

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900006-1

7 January 2021

An effective immunization and cancer treatment with activated dendritic cells transduced with full-length wild-type p53.

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900006-1

7 January 2021

Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900006-1

7 January 2021

Sequential development of an angiogenic phenotype by human fibroblasts progressing to tumorigenicity

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900006-1

7 January 2021

p53 induces angiogenesis-restricted dormancy in a mouse fibrosarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900006-1

7 January 2021

Differentiation Therapy of Acute Promyelocytic Leukemia with Tretinoin (All-trans-Retinoic Acid)

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900006-1

7 January 2021

The prognostic value of histologic subtypes in primary extremity liposarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900006-1

7 January 2021

Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900006-1

7 January 2021

Adipocyte-specific transcription factor ARF6 is a heterodimeric complex of two nuclear hormone receptors, PPAR gamma and RXR alpha

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900006-1

7 January 2021

mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900006-1

7 January 2021

Terminal differentiation of human liposarcoma cells induced by ligands for peroxisome proliferator-activated receptor gamma and the retinoid X receptor.

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900006-1

7 January 2021

Lovastatin-induced apoptosis of human medulloblastoma cell lines in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900006-1

7 January 2021

Suppression of murine neuroblastoma growth in vivo by mevinolin, a competitive inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A reductase

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900006-1

7 January 2021

Lovastatin induces apoptosis in a primitive neuroectodermal tumor cell line in association with RB down-regulation and loss of the G1 checkpoint

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900006-1

7 January 2021

Expression of disialogangliosides GD2 and GD3 on human soft tissue sarcomas

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900006-1

7 January 2021

Immunotherapeutic approaches to sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900006-1

7 January 2021

MAGE antigen expression in monophasic and biphasic synovial sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900006-1

7 January 2021

Expression of MAGE-antigens in normal tissues and cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900006-1

7 January 2021

Pulsing of dendritic cells with cell lysates from either B16 melanoma or MCA-106 fibrosarcoma yields equally effective vaccines against B16 tumors in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900006-1

7 January 2021

Murine dendritic cells pulsed with whole tumor lysates mediate potent antitumor immune responses in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900006-1

7 January 2021

Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900006-1

7 January 2021

Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900006-1

7 January 2021

Mesenchymal tumors of the gastrointestinal tract: a paradise for acronyms (STUMP, GIST, GANT, and now GIPACT), implication of c-kit in genesis, and yet another of the many emerging roles of the interstitial cell of Cajal in the pathogenesis of gastr

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900006-1

7 January 2021

Mutations in exon 11 of c-Kit occur preferentially in malignant versus benign gastrointestinal stromal tumors and do not occur in leiomyomas or leiomyosarcomas

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900006-1

7 January 2021

Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900006-1

7 January 2021

Familial gastrointestinal stromal tumours with germline mutation of the KIT gene.

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900006-1

7 January 2021

STI571 inactivation of the gastrointestinal stromal tumor c-KIT oncoprotein: biological and clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900006-1

7 January 2021

Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900006-1

7 January 2021

The EWS-WT1 translocation product induces PDGFA in desmoplastic small round-cell tumour

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900006-1

7 January 2021

In vivo antitumor effect of vascular targeting combined with either ionizing radiation or anti-angiogenesis treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900006-1

7 January 2021

Interaction between combretastatin A-4 disodium phosphate and radiation in murine tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900006-1

7 January 2021

Tumor cell interactions with the extracellular matrix during invasion and metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900006-1

7 January 2021

Metalloproteinase expression and prognosis in soft tissue sarcomas

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900006-1

7 January 2021

Matrix metalloproteinase-2 is required for the switch to the angiogenic phenotype in a tumor model

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900006-1

7 January 2021

Isolated limb perfusion for extremity sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900006-1

7 January 2021

10.1016/S1055-3207(03)00006-1

Identifiers

DOI

1 reference

7 August 2017

1 reference

PubMed ID

12916466